Abstract. Neutrophil elastase (NE) is a neutrophil-derived serine proteinase with specificity for a broad range of substrates. NE has been reported to be associated with the pathogenesis of several conditions, particularly that of pulmonary diseases. Previous studies have shown that NE can cleave the pro-myelocyte -retinoic acid receptor-alpha chimeric protein and is important for the development of acute pro-myelocytic leukemia. To further elucidate the role of NE in acute pro-myelocytic leukemia, the present study successfully constructed a lentiviral vector containing the NE gene (LV5-NE), which was transfected into NB4 acute pro-myelocytic leukemia cells. The effects of NE overexpression in NB4 cells were detected using a Cell-Counting Kit-8 assay, flow cytometry and western blot analysis. The results showed that NE significantly promoted the proliferation of NB4 cells, inhibited cell apoptosis and apoptotic signaling, and led the activation of Akt. In an additional experiment, a vector expressing small hairpin RNA targeting NE was constructed to assess the effects of NE knockdown in U937 cells. Western blot analysis revealed that apoptotic signaling was increased, while Akt activation was decreased following silencing of NE. The results of the present study may indicate that NE activates the phosphoinositide-3 kinase/Akt signaling pathway in leukemia cells to inhibit apoptosis and enhance cell proliferation, and may therefore represent a molecular target for the treatment of pro-myelocytic leukemia.
Introduction
Acute pro-myelocytic leukemia (APL), which accounts for ~10% of all acute myeloid leukemia (AML) cases, is classified as the M3 subtype of AML within the French-American-British morphological classification system (1), A reciprocal chromosomal translocation affects the long arm of chromosomes 17 and 15 at the site of the retinoic acid receptor alpha (RARα) gene and the pro-myelocyte (PML) gene, respectively, resulting in a PML-RARA fusion gene, which leads to formation of the PML-RARα chimeric protein in 95% of APL cases (2-7). The PML and RARα oncoproteins, whose roles in leukemogenesis have been elucidated, are known to be targeted by specific biomolecules that are active in the disease (8) .
Neutrophil elastase (NE), also known as human leukocyte elastase, is a neutrophil-derived serine proteinase with specificity for a broad range of substrates and is encoded by Elane, formerly known as Ela2 (9) . The major physiological role of NE is to kill engulfed microorganisms within neutrophil phagolysosomes (10) (11) (12) (13) . NE has been reported to be associated with the pathogenesis of several diseases, including acute lung injury, cystic fibrosis, emphysema and leukemia (14) (15) (16) (17) . NE has also been characterized by its ability to cleave extracellular matrix proteins (18) . NE is able to cleave the fusion protein PML-RARα into two different protein variants (16, 18, 19) . This type of cleavage action has a role in the development of APL (20, 21) . A previous study by our group showed that NE has a role in the development of leukemia (22) . However, the mechanism underlying the effect of NE in APL remain to be fully elucidated.
In order to explore the biological functions of NE in APL, NE was overexpressed using a constructed lentiviral vector. The effects of NE on NB4 cell proliferation and apoptosis were assessed and the possible mechanistic functions of NE were explored in APL cell lines. In addition, NE was silenced using small hairpin (sh)RNA to clarify its effect on the PI3K/Akt pathway in U937 cells. were maintained in RPMI-1640 medium (Gibco) with 10% FBS. Cells were cultured at 37˚C in a humidified atmosphere containing 5% CO 2 , and the culture medium was replaced at two-day intervals.
Materials and methods
Construction of lentivirus. Shuttle plasmid and packing plasmid vector maps (Genepharma, Shanghai, China) are shown in Fig. 1A and B, respectively. A recombinant plasmid containing a lentiviral vector and three original auxiliary packaging vectors was constructed. NE was inserted into the LV5 plasmid but was not inserted for the negative control group. The three different plasmids were extracted with endo-free and high purity kits (Takara Bio, Inc., Otsu, Japan). The restriction enzymes used were NotⅠ and BamHⅠ (Takara Bio, Inc.). The recombinant plasmid and vectors were co-transfected into 293T cells using RNAi-Mate transfection reagent (Genepharma). The medium was replaced with complete medium after transfection for 6 h. After culture for 72 h, the cell supernatant was collected, which contained the lentivirus. Following concentration of the supernatant, the viral titer was determined.
Titer detection. 293T cells were cultured in 96-well plates at a density of 0.5-10x10 3 cells/100 µl per well for 24 h. Then 90 µl complete medium (DMEM+10% FBS) was added to 7-10 EP tube. Original lentivirus (10 µl) was added to the first tube. Then 10 µl of the mixed suspension from the first tube was added to the second tube. This was repeated until each tube had been filled. Then, 90 µl of culture medium was discarded and the mixed suspension by concentration gradient (lowest to highest) was added to the cells. When cells had been cultured at 37˚C in a humidified atmosphere containing 5% CO 2 for 48 h, 100 µl of culture medium was added to each well. The cells were cultured for a further 72 h and subsequently counted based on the expression of green fluorescent protein (GFP) under an Eclipse 80i, Nikon fluorescence microscope (Nikon, Tokyo, Japan). The titer was calculated using the following formula: TU/µl = (PxN/100xV)/DF, where P is the percentage of GFP-positive cells, N is the number of cells, V is the virus dilution volume and DF is the dilution factor. Lentiviral transfection. NB4 cells in the logarithmic growth phase (1x10 5 cells/well) were seeded in a 24-well plate. These cells were transfected with the GFP-expressing lentiviral vector LV5-NC and the NE-expressing recombinant lentivirus LV5-NE, and 1 µg/ml polybrene (Genepharma) was added. After culture for 24 h, the medium was refreshed. Fluorescence was detected following 48-72 h of incubation using the fluorescence microscope. The LV5-NE-and LV5-NC-transfected NB4 cells were screened with puromycin (Sigma-Aldrich, St. Louis, MO, USA) and successful transfectants were used for subsequent experiments. Experiments were performed on untransfected NB4 cells as well as on LV5-NE-and LV5-NC-transfected NB4 cells.
Transient transfection. U937 cells (2.5x10 5 /ml) in the logarithmic growth phase were seeded in six-well plates. For transfection, 5 µl siRNA and 5 µl Lipofectamine 2000 (Invitrogen; Thermo Fisher Scentific, Inc.) were diluted in 100 μl Opti-MEM (Invitrogen) separately. The siRNA and Lipofectamine 2000 were then gently mixed and incubated for 25 min at room temperature. The siRNA-Lipofectamine 2000 complexes were subsequently added to each well and mixed by gentle agitation. The siRNA was purchased from RiboBio (Guangzhou, China) and the sequences of the NE-specific siRNAs were as follows: 5'-GAUCGACUCUAUCAUCCAAdTdT-3' and 3'-dTdTCUAGCUGAGAUAGUAGGUU-5'. The resulting solution was added to each well, followed by incubation for 6 h. Subsequently, 1 ml fresh complete medium was added. The transfected cells were named as U937/NE-shRNA. In the negative control group, U937/shRNA-NC cells were processed similarly. Following 48 h of transfection, the successfully transfected cells were verified by fluorescent microscopy. The transfection efficiency was expressed as the percentage of red fluorescence protein-positive cells. In subsequent experiments, native U937 cells as well as U937/shRNA-NC and U937/NE-shRNA cells were used.
RNA isolation and reverse-transcription quantitative polymerase chain reaction (RT-qPCR) analysis.
In each group of cells, TRIzol (Invitrogen, Thermo Fisher Scientific, Inc.) was used to extract total RNA, which was reverse transcribed into complementary DNA. In brief, 10 µl RNA solution (Takara Bio, Inc.) was subjected to RT. PCR amplification was then performed in a ThermoScript™ RT-PCR system (Invitrogen) using a PreTaq kit (Takara Bio, Inc.). All the primers were synthesized from Sangon Biotech, Co., Ltd. (Shanghai, China). The specific primers for NE of RT-PCR were 5'-CGG AAT TCA TGA CCC TCG GCC GCC GA-3' (forward) and 5'-CCG CTC GAG TCA GTG GGT CCT GCT GGC-3' (reverse). The reaction mixture contained 1 µl PrimeScriptRT Enzyme mix I (Takara Bio, Inc.), 1 µl (10 µM of each primer and 500 ng RNA in a final volume of 20 µl). Thermocycling conditions were as follows: Reverse transcription at 37˚C for 15 min, then reverse transcriptase inactivation reaction at 85˚C for 5 sec. The RT-PCR products were verified by agarose gel (Invitrogen; Thermo Fisher Scentific, Inc.). The specific primers for NE used for qPCR were 5'-ACT GCG TGG CGA ATG TAA-3' (forward) and 5'-CGA TGT CGT TGA GCA AGT T-3' (reverse). Primers for GAPDH were 5'-GAA GGT GAA GGT CGG AGTC-3' (forward) and 5'-GAA GAT GGT GAT GGG ATT TC-3' (reverse). The reaction mixture contained 5 µl PreTaq Enzyme, 0.5 µl (10 µM) of each primer and 100 ng cDNA in a final volume of 10 µl. Thermocycling conditions were as follows: Pre-denaturation at 95˚C for 5 min, 39 cycles of denaturation at 95˚C for 30 sec, annealing at 60˚C for 30 sec and extension at 72˚C for 30 sec, and a final extension at 95˚C for 5 min. GAPDH was used as a reference gene and the RT-PCR products were verified by agarose gel with the DL 2,000 DNA maker (Takara Bio, Inc.). Quantity One Software (Bio-Rad Laboratories, Inc., Hercules, CA, USA) was used for quantification of mRNA levels. Expression of NE, relative to GAPDH was determined using the 2 -ΔΔCq method (23 4 /well) were seeded in 96-well plates and incubated for 1-4 days. Subsequently, 10 µl CCK-8 solution (5 mg/ml) was added to each well, and cells were incubated for 2 h at 37˚C. The absorbance at 450 nm was measured using an Eon spectrophotometer (Bio-Rad Laboratories, Inc.) and plotted to obtain cell growth curves. The experiment was repeated three times in triplicate wells for each condition.
Flow cytometric analysis. The cells were routinely collected and centrifuged at 500 x g for 5 min at room temperature. After the cells had been washed twice with phosphate-buffered saline (PBS), a staining mixture was prepared containing 5 µl Annexin-V-fluorescein isothiocyanate fluorescent dye (Sigma-Aldrich) and 5 µl propidium iodide (Sigma-Aldrich). The rate of cell apoptosis was analyzed using a FACsorter (BD Biosciences, San Jose, CA, USA) following a 15 min incubation at room temperature. Furthermore, 5x10 5 cells were collected, centrifuged at 500 x g for 5 min and washed with pre-cooled PBS twice. The supernatant was discarded, precooled 70% ethanol (1 ml) was added and the samples were fixed overnight at 4˚C. Following fixation, the samples were centrifuged at 500 x g for 5 min and washed with 1 ml PBS twice. The cells were resuspended in 100 µl of 1 mg/ml RNase solution (Takara Bio, Inc.). in a 37˚C water bath for 30 min. Following incubation, 150 µl of 50 µg/ml propidium iodide staining solution was added and incubated for 30 min in dark at room temperature. The cell cycle distribution was detected using a FACsorter. Experiments were repeated three times.
Statistical analysis.
Values are expressed as the mean ± standard deviation. Statistical analysis was performed using SPSS 17.0 software (SPSS, Inc., Chicago, IL, USA). An independent samples t-test was employed for comparing the means between two groups. P<0.05 was considered to indicate a statistically significant difference. Each experiment was repeated at least three times.
Results

Vector-mediated expression of NE in NB4 cells.
The recombinant lentivirus LV5-NE was transfected into NB4 cells to induce NE overexpression. The percentage of GFP-positive cells was ~100%, demonstrating that after screening with puromycin, A B all cells were positive transfectants (Fig. 2) . RT-PCR and qPCR assays showed that NE mRNA was expressed in the LV5-NE-transfected cells (P<0.05 vs. control), whereas native NB4 cells or LV5-NC-transfected cells showed no expression of NE (Fig. 3A) . Furthermore, western blot analysis also showed that NE protein was expressed in the LV5-NE-transfected cells (P<0.05 vs. control), while NE protein expression was low in native NB4 cells and LV5-NC-transfected cells (Fig. 3B) .
NE enhances the proliferation of NB4 cells.
The CCK-8 assay showed that overexpression of NE promoted the proliferation of NB4 cells when compared with that of the control cells (P<0.05) (Fig. 4A) . Furthermore, flow cytometric analysis showed that the percentage of LV5-NE-transfected NB4 cells in S phase was significantly higher than that of native or LV5-NC-transfected NB4 cells (P<0.05) (Fig. 4B-D) .
NE inhibits apoptosis in NB4 cells. Flow cytometric analysis
showed that the apoptotic rate of NB4 cells was significantly decreased following LV5-NE transfection, while LV5-NC had no significant effect (Fig. 5) . Furthermore, western blot analysis demonstrated that the expression of anti-apoptotic protein B-cell lymphoma 2 (Bcl-2) was upregulated in NB4 cells following LV5-NE transfection (P<0.05), while LV5-NC had no effect on Bcl-2 levels (Fig. 6) . The apoptotic protein Bcl-2-associated X (Bax) was not affected by any of the vectors. These results indicated that NE inhibits apoptosis of NB4 cells by upregulating the expression of the cell survival protein Bcl-2.
NE activates the phosphoinositide-3 kinase (PI3K)/Akt pathway in NB4 cells.
Western blot analysis showed increased expression of phosphorylated (activated) Akt in NB4 cells following transfection with LV5-NE (P<0.05), while LV5-NC had no obvious effect on Akt phosphorylation and levels of total Akt were not affected by any of the vectors (Fig. 6A ). This result indicated that NE may promote the proliferation of NB4 cells by activation of the PI3K/Akt pathway.
Knockdown of NE in U937 cells. NE-shRNA was used to silence NE in U937 cells. Transfection with NE-shRNA and shRNA-NC vectors was confirmed by fluorescence microscopy (Fig. 7A) , and RT-qPCR demonstrated that the mRNA expression of NE was efficiently reduced in the U937/NE-shRNA cells (P<0.05), while shRNA-NC did not affect the mRNA levels of NE (Fig.  7B) . Western blot analysis showed that the protein expression of NE in U937 cells was also decreased by NE-shRNA (P<0.05), while not being affected by shRNA-NC (Fig 7C) .
NE knockdown deactivates the PI3K/Akt pathway and induces apoptotic signaling in U937 cells.
Western blot analysis indicated that the expression of phosphorylated (activated) Akt and Bcl-2 in U937/NE-shRNA cells were decreased compared with those in U937 or U937/shRNA-NC cells (P<0.05) (Fig. 8) . However, the protein expression levels of total Akt and Bax were in U937 cells were not significantly affected by shRNA-NE (P>0.05) (Fig 8) . Collectively, these results further confirmed that NE has an oncogenic role in leukemia cells, and that its knockdown leads to deactivation of the PI3K/Akt pathway and induction of apoptosis.
Discussion
NE belongs to the chymotrypsin family of serine proteases and has been reported to be associated with numerous pathological conditions. Previous studies have shown that NE can promote the proliferation, diffusion and metastasis of tumor cells, and is closely associated with tumor occurrence, development and prognosis. NE is also crucially involved in the defense against bacterial pathogens through various mechanisms, including cell (12), or regulation of the inflammatory response by targeting chemokines, cytokines and their receptors (25, 26) . The underlying mechanisms of the roles of NE in diseases have been elucidated in pulmonary conditions in particular, and it is known that NE causes tissue damage to decrease the tolerance of the host towards pulmonary infection with Burkholderia species (27) . NE was first reported to promote cellular proliferation in psoriasis, a benign neoplastic disorder of keratinocytes (28) . NE has been reported to promote lung cancer cell proliferation in vitro and in vivo by degrading a novel target substrate, insulin receptor substrate-1, leading to hyperactivity of PI3K and ultimately resulting in enhanced tumor cell proliferation (29, 30) . NE can also selectively bind to the cancer cell surface and undergo classic clathrin pit-mediated (32); however, its role in acute pro-myelocytic leukemia has not been reported. APL is a rare form of cancer, and targeted therapy has proven to successfully eradicate leukemia stem cells in the majority of affected patients (33, 34) . Exploration of the possible mechanism of the roles of NE in APL may provide a 
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and the inhibition of NE induced hepatic microvascular responses (36, 37) . A previous study by our group showed that NE promoted the proliferation and inhibited apoptosis of K562 cells (38) . In the present study, a lentivirus expressing the NE gene was constructed and transfected into NB4 cells, which promoted proliferation and inhibited apoptosis; furthermore, the S-phase population of the cell cycle was increased. This was paralleled by increased activation of Akt, suggesting that NE may promote NB4 cell proliferation by activation of the PI3K/Akt pathway.
